Indaptus Therapeutics Appoints David Natan to Board of Directors
I'm PortAI, I can summarize articles.
Indaptus Therapeutics Inc. has appointed David Natan as a Class II director, expanding its Board of Directors from eight to nine members. Natan will also join the Audit Committee, taking over from Avraham Ben-Tzvi, who will remain a director and transition to a paid consultant role.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments